| Literature DB >> 30902636 |
Yunyun Yang1, Liping Li1, Linjie Yuan1, Xiaoying Zhou1, Jianxin Duan2, Hongying Xiao3, Ningning Cai4, Shuai Han1, Xianqiang Ma1, Weidong Liu5, Chun-Chi Chen5, Lingle Wang6, Xin Li3, Jiahuan Chen7, Ning Kang7, Jing Chen7, Zhixun Shen7, Satish R Malwal8, Wanli Liu7, Yan Shi7, Eric Oldfield9, Rey-Ting Guo10, Yonghui Zhang11.
Abstract
Human Vγ9Vδ2 T cells respond to microbial infections and malignancy by sensing diphosphate-containing metabolites called phosphoantigens, which bind to the intracellular domain of butyrophilin 3A1, triggering extracellular interactions with the Vγ9Vδ2 T cell receptor (TCR). Here, we examined the molecular basis of this "inside-out" triggering mechanism. Crystal structures of intracellular butyrophilin 3A proteins alone or in complex with the potent microbial phosphoantigen HMBPP or a synthetic analog revealed key features of phosphoantigens and butyrophilins required for γδ T cell activation. Analyses with chemical probes and molecular dynamic simulations demonstrated that dimerized intracellular proteins cooperate in sensing HMBPP to enhance the efficiency of γδ T cell activation. HMBPP binding to butyrophilin doubled the binding force between a γδ T cell and a target cell during "outside" signaling, as measured by single-cell force microscopy. Our findings provide insight into the "inside-out" triggering of Vγ9Vδ2 T cell activation by phosphoantigen-bound butyrophilin, facilitating immunotherapeutic drug design.Entities:
Keywords: HMBPP; T cell antigen recognition; Vγ9Vδ2 T cells; allogenic cell therapy; butyrophilin 3A1; cell therapy; immune stimulant; immunotherapy; inside-out signaling; phosphoantigens
Mesh:
Substances:
Year: 2019 PMID: 30902636 DOI: 10.1016/j.immuni.2019.02.016
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745